Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2024-10-01
|
| Series: | Dermatology and Therapy |
| Online Access: | https://doi.org/10.1007/s13555-024-01269-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846165581947994112 |
|---|---|
| author | Jonathan I. Silverberg Andreas Wollenberg Linda Stein Gold James Del Rosso Gil Yosipovitch Peter Lio Jose-Manuel Carrascosa Gaia Gallo Yuxin Ding Zhenhui Xu Marta Casillas Evangeline Pierce Helena Agell Sonja Ständer |
| author_facet | Jonathan I. Silverberg Andreas Wollenberg Linda Stein Gold James Del Rosso Gil Yosipovitch Peter Lio Jose-Manuel Carrascosa Gaia Gallo Yuxin Ding Zhenhui Xu Marta Casillas Evangeline Pierce Helena Agell Sonja Ständer |
| author_sort | Jonathan I. Silverberg |
| collection | DOAJ |
| format | Article |
| id | doaj-art-d06ef00c21c84ee48845e758fed856a9 |
| institution | Kabale University |
| issn | 2193-8210 2190-9172 |
| language | English |
| publishDate | 2024-10-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Dermatology and Therapy |
| spelling | doaj-art-d06ef00c21c84ee48845e758fed856a92024-11-17T12:10:33ZengAdis, Springer HealthcareDermatology and Therapy2193-82102190-91722024-10-0114113195319610.1007/s13555-024-01269-yPublisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab TreatmentJonathan I. Silverberg0Andreas Wollenberg1Linda Stein Gold2James Del Rosso3Gil Yosipovitch4Peter Lio5Jose-Manuel Carrascosa6Gaia Gallo7Yuxin Ding8Zhenhui Xu9Marta Casillas10Evangeline Pierce11Helena Agell12Sonja Ständer13George Washington University School of MedicineDepartment of Dermatology and Allergy, University Hospital AugsburgHenry Ford Health SystemJDR Dermatology ResearchMiller School of Medicine, University of MiamiNorthwestern University Feinberg School of MedicineHospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, IGTPEli Lilly and CompanyEli Lilly and CompanyCIMS Global LLCEli Lilly and CompanyEli Lilly and CompanyAlmirall S.A.Center for Chronic Pruritus and Department of Dermatology, University Hospital Münsterhttps://doi.org/10.1007/s13555-024-01269-y |
| spellingShingle | Jonathan I. Silverberg Andreas Wollenberg Linda Stein Gold James Del Rosso Gil Yosipovitch Peter Lio Jose-Manuel Carrascosa Gaia Gallo Yuxin Ding Zhenhui Xu Marta Casillas Evangeline Pierce Helena Agell Sonja Ständer Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment Dermatology and Therapy |
| title | Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment |
| title_full | Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment |
| title_fullStr | Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment |
| title_full_unstemmed | Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment |
| title_short | Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment |
| title_sort | publisher correction patients with moderate to severe atopic dermatitis maintain stable response with no or minimal fluctuations with 1 year of lebrikizumab treatment |
| url | https://doi.org/10.1007/s13555-024-01269-y |
| work_keys_str_mv | AT jonathanisilverberg publishercorrectionpatientswithmoderatetosevereatopicdermatitismaintainstableresponsewithnoorminimalfluctuationswith1yearoflebrikizumabtreatment AT andreaswollenberg publishercorrectionpatientswithmoderatetosevereatopicdermatitismaintainstableresponsewithnoorminimalfluctuationswith1yearoflebrikizumabtreatment AT lindasteingold publishercorrectionpatientswithmoderatetosevereatopicdermatitismaintainstableresponsewithnoorminimalfluctuationswith1yearoflebrikizumabtreatment AT jamesdelrosso publishercorrectionpatientswithmoderatetosevereatopicdermatitismaintainstableresponsewithnoorminimalfluctuationswith1yearoflebrikizumabtreatment AT gilyosipovitch publishercorrectionpatientswithmoderatetosevereatopicdermatitismaintainstableresponsewithnoorminimalfluctuationswith1yearoflebrikizumabtreatment AT peterlio publishercorrectionpatientswithmoderatetosevereatopicdermatitismaintainstableresponsewithnoorminimalfluctuationswith1yearoflebrikizumabtreatment AT josemanuelcarrascosa publishercorrectionpatientswithmoderatetosevereatopicdermatitismaintainstableresponsewithnoorminimalfluctuationswith1yearoflebrikizumabtreatment AT gaiagallo publishercorrectionpatientswithmoderatetosevereatopicdermatitismaintainstableresponsewithnoorminimalfluctuationswith1yearoflebrikizumabtreatment AT yuxinding publishercorrectionpatientswithmoderatetosevereatopicdermatitismaintainstableresponsewithnoorminimalfluctuationswith1yearoflebrikizumabtreatment AT zhenhuixu publishercorrectionpatientswithmoderatetosevereatopicdermatitismaintainstableresponsewithnoorminimalfluctuationswith1yearoflebrikizumabtreatment AT martacasillas publishercorrectionpatientswithmoderatetosevereatopicdermatitismaintainstableresponsewithnoorminimalfluctuationswith1yearoflebrikizumabtreatment AT evangelinepierce publishercorrectionpatientswithmoderatetosevereatopicdermatitismaintainstableresponsewithnoorminimalfluctuationswith1yearoflebrikizumabtreatment AT helenaagell publishercorrectionpatientswithmoderatetosevereatopicdermatitismaintainstableresponsewithnoorminimalfluctuationswith1yearoflebrikizumabtreatment AT sonjastander publishercorrectionpatientswithmoderatetosevereatopicdermatitismaintainstableresponsewithnoorminimalfluctuationswith1yearoflebrikizumabtreatment |